We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

a professor at UC Law San Francisco. Such heightened risk could lead vaccine makers to raise prices or pull a product off the ...

In a presentation at JPMorgan’s healthcare investment conference in San Francisco late Monday, Merck executives presented a rosy picture as the company heads toward the 2028 patent expiration.

The latest version of Keytruda could eventually capture between 30% and 40% of the market for the original, Merck CEO Rob Davis said at the JPMorgan Healthcare Conference in San Francisco on Monday.

South San Francisco-based Day One is so convinced that ... The financial details of the Merck licensing deal haven’t been made public. The agreement is the second licensing deal for Day One ...

Merck and Japan-based Eisai said on Friday ... Philips CEO sees subdued China sales this year Healthcare dealmakers gathering in San Francisco for the industry's premier annual conference this ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... Get top local stories in San Diego delivered to you every morning. Sign up for NBC San Diego's News Headlines newsletter. He also pointed ...

Robert F Kennedy Jr played an instrumental role in organising mass litigation against drugmaker Merck over its Gardasil ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... at the JPMorgan healthcare conference in San Francisco, where he saw many pharmaceutical companies that he ...